Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824804) titled 'Phase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With Obesity' on Sept. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Shanghai Minwei Biotechnology Co., Ltd
Condition:
Healthy Volunteers
Obesity
Intervention:
Drug: MWN117
Drug: MWN117
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 18, 2026
Target Sample Size: 48
Countries of Recruitment:
China
To know more, visit https://clini...